ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts9999
Avg. Estimate-1.41-1.38-5.31-4.57
Low estimate-1.79-1.68-6.3-6.03
High estimate-1.15-1.18-4.44-3.54
Year ago EPS-1.44-1.6-5.67-5.31
Revenue estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts8888
Avg. EstimateN/AN/AN/A7.81M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A44.23M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/201929/06/201929/09/201930/12/2019
Est. EPS-1.51-1.5-1.44-1.34
Actual EPS-1.44-1.6-1.31-1.36
Difference0.07-0.10.13-0.02
Surprise %4.60%-6.70%9.00%-1.50%
EPS trendCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Current estimate-1.41-1.38-5.31-4.57
7 days ago-1.41-1.38-5.31-4.57
30 days ago-1.44-1.34-5.06-4.55
60 days ago-1.44-1.32-4.98-4.55
90 days ago-1.43-1.31-4.93-4.5
EPS revisionsCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATRAIndustrySectorS&P 500
Current qtr.2.10%N/AN/A-0.06
Next qtr.13.80%N/AN/A-0.04
Current year6.30%N/AN/A-0.05
Next year13.90%N/AN/A0.17
Next 5 years (per annum)N/AN/AN/A0.06
Past 5 years (per annum)N/AN/AN/AN/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more